IL-3 is a novel target to interfere with tumor vasculature
Por um escritor misterioso
Descrição
Macrophage CD5L is a target for cancer immunotherapy - eBioMedicine
Frontiers Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer
IJMS, Free Full-Text
Tumor vasculature vs tumor cell targeting: Understanding the latest trends in using functional nanoparticles for cancer treatment - ScienceDirect
PDF) IL-3 is a novel target to interfere with tumor vasculature
Cancers, Free Full-Text
Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
JPM, Free Full-Text
Checkpoint blockade to overcome acquired resistance to immunocytokine
Frontiers Nanoparticle-Based Therapies for Turning Cold Tumors Hot: How to Treat an Immunosuppressive Tumor Microenvironment
de
por adulto (o preço varia de acordo com o tamanho do grupo)
